Condition
HBV-related Liver Cirrhosis
Total Trials
5
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 4 (2)
Trial Status
Recruiting2
Unknown2
Not Yet Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07275554Recruiting
Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure
NCT07183293Not ApplicableNot Yet RecruitingPrimary
A Study on Peginterferon Alfa-2b Combined With NAs in Compensated HBV Cirrhosis
NCT07160946RecruitingPrimary
Risk Assessment for HBV-Related Liver Cancer
NCT01799486Phase 4UnknownPrimary
Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial
NCT01693679Phase 4UnknownPrimary
Telbivudine Renoprotective Effect in Patients With HBV-related Liver Cirrhosis
Showing all 5 trials